RFBio is a global company at the forefront of the Medical Device and Biotechnology markets.
RFBio registers and distributes medical devices and cosmetics across more than 16 countries worldwide, including the European Union.
[Medical Device Export Markets]
[Term]CPNP (Cosmetic Product Notification Portal)
Europe
United Kingdom, Ukraine, Russia
Asia
South Korea, Thailand, Vietnam, Indonesia, Uzbekistan, Azerbaijan
Middle East & Africa
Türkiye, Syria, Iraq, Egypt, Saudi Arabia, United Arab Emirates, Kuwait, Morocco
Americas
Mexico, Colombia, Peru
[Cosmetics Export Markets]
[Term]CPNP (Cosmetic Product Notification Portal)
Europe
United Kingdom, Russia (EAC), Belarus (EAC), Armenia (EAC)
Asia
South Korea, China, Taiwan, Vietnam, Thailand, Kazakhstan (EAC), Kyrgyzstan (EAC)
Middle East
Türkiye, Israel, United Arab Emirates, Saudi Arabia
Americas
Ecuador, Peru
Affiliated company
팜젠사이언스
PharmGen Science
Driven by strong R&D investment, PharmGen Science is advancing toward becoming the global No.1 specialty pharmaceutical company in gastrointestinal therapeutics. The company has established a pipeline of 10 novel drug candidates, including the world's first macrocyclic liver-specific MRI contrast agent, and continues to develop innovative pharmaceuticals and medical devices based on its proprietary formulation technologies.
As a leading innovator in the global in vitro diagnostics (IVD) industry, the company has developed highly sensitive rapid diagnostic tests (RDTs) and secured FDA approval. Building on this foundation, it is now driving a strategic transformation into a global total wellness platform company.
Founded in 2013, the company is a leading developer of next-generation in vitro diagnostic (IVD) medical devices. Through its strategic partnership with Access Bio, it is pursuing entry into the U.S. laboratory-developed test (LDT) market, the largest diagnostic testing market in the world.
The company is at the forefront of the wellness and cosmedical business, delivering innovative healthcare solutions powered by proprietary pharmaceutical technologies.
RF Bio Co., Ltd. (hereinafter referred to as the "Company") processes the following personal data:
1) Customer Consultation Service Operation: Company name, personal name, contact information, email address, complaint details.
2) The following personal data may be automatically generated and collected during the use of internet services
: IP address, cookie, access log, MAC address, service usage record, visit record, misuse record, etc.
2. Purpose of Personal Data Processing:
The Company processes personal data for the following purposes. Personal data being processed will not be used for purposes other than the following.
If the purpose of use changes, necessary measures such as obtaining separate consent will be taken in accordance with Article 18 of the Personal Information Protection Act:
To operate customer consultation services, personal data is processed for verifying the identity of the complainant, confirming the complaint, contacting and notifying for factual investigation, and notifying the result of processing.
3. Processing and Retention Period of Personal Data:
The Company processes and retains personal data within the personal data retention and use period as stipulated by law or within the agreed-upon personal data retention and use period when collecting personal data from the data subject. It is retained during the period of customer service operation and is not used for any other purpose.
4. Right to Refuse Consent to Collection and Use of Personal Data:
Users have the right to disagree with the above collection and use of personal data. However,
the collection and use of personal data are essential for the Company to operate the site, and users who do not agree
to the collection and use of personal data are restricted from using customer consultation services.
